Algernon Pharmaceuticals Shareholders Equity (Quarterly) Trends

Algernon Pharmaceuticals Inc (AGN.CX)

0.085 0.00 (0.00%) CAD | CNSX | Nov 12, 14:04

Shareholders Equity (Quarterly) Chart

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2015. Upgrade now.

Date	Value
November 30, 2022	4.436M
August 31, 2022	5.625M
May 31, 2022	5.556M
February 28, 2022	6.342M
November 30, 2021	7.893M
August 31, 2021	9.115M
May 31, 2021	9.727M
February 28, 2021	9.231M
November 30, 2020	9.103M
August 31, 2020	12.22M
May 31, 2020	13.35M
February 29, 2020	7.475M
November 30, 2019	6.478M
August 31, 2019	4.973M
May 31, 2019	5.397M

Date	Value
February 28, 2019	5.930M
November 30, 2018	6.226M
August 31, 2018	1.366M
May 31, 2018	1.458M
February 28, 2018	1.623M
November 30, 2017	1.399M
August 31, 2017	1.589M
May 31, 2017	1.888M
February 28, 2017	2.593M
November 30, 2016	2.922M
August 31, 2016	2.123M
May 31, 2016	2.564M
February 29, 2016	2.564M
November 30, 2015	2.755M

Shareholders' Equity Definition

Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

4.436M

Minimum

Nov 2022

13.35M

Maximum

May 2020

8.196M

Average

7.893M

Median

Nov 2021

Shareholders Equity (Quarterly) Benchmarks

Biocure Technology Inc	1.559M
Core One Labs Inc	5.641M
Restart Life Sciences Corp	-1.046M
Nanosphere Health Sciences Inc	-2.231M
Lobe Sciences Ltd	-1.113M

Shareholders Equity (Quarterly) Related Metrics

Total Assets (Quarterly)	6.674M
Total Liabilities (Quarterly)	2.237M